Imaavy (nipocalimab-aahu) is the first FcRn blocker approved to treat warm autoimmune hemolytic anemia in patients aged 12 years and older.

Fewer cases of mpox virus (MPXV) infection were reported in 2025 than 2024, but the number of reported cases during September to October 2025 was double that se ...

Melissa Glassford, DNP, discusses clinical strategies for managing GLP-1 therapy gaps, dose titration, weight plateaus, and ...

Longer habitual fasting duration is associated with faster chronic disease accumulation in those aged 78 years and older ...

A series of lawsuits challenges state laws governing practice authority and physician supervision for nurse practitioners.

Structural barriers, including reliance on predicate-based pathways and misaligned financial incentives, discourage rigorous evaluation of AI tools.

HealthDay News — The global health workforce has expanded since 1990, mainly due to an increase in female health workers, according to a study published online Aug. 18 in The Lancet Public Health.

By better defining sarcopenia risk factors, rheumatologists can identify at-risk patients earlier in the course of their disease.

Yearly diagnostic screening for migraine from adolescence through menopause can address widespread underdiagnosis and improve ...

This case study highlights the importance of considering pelvic teratomas in the differential diagnosis of young female ...